Sheena Mumick
Merck & Co., Inc., Rahway, NJ, USA (United States)(US)
Publications by Year
Research Areas
Pharmacogenetics and Drug Metabolism, Diabetes Treatment and Management, Regulation of Appetite and Obesity, Adipokines, Inflammation, and Metabolic Diseases, Drug Transport and Resistance Mechanisms
Most-Cited Works
- → Validation of candidate causal genes for obesity that affect shared metabolic pathways and networks(2009)281 cited
- → Diet Induction of Monocyte Chemoattractant Protein‐1 and its Impact on Obesity(2005)228 cited
- → Polypharmacy through Phage Display: Selection of Glucagon and GLP-1 Receptor Co-agonists from a Phage-Displayed Peptide Library(2018)10 cited
- → Deficiency in Cytosolic Malic Enzyme Does Not Increase Acetaminophen‐Induced Hepato‐Toxicity(2008)10 cited
- → Discovery of MK-1462: GLP-1 and Glucagon Receptor Dual Agonist for the Treatment of Obesity and Diabetes(2022)9 cited